glp-1 drugs ro Offers Eli Lilly's Foundayo™, the Newest Innovation Weight Loss Injections: Costs, How
Description
doi: 10.1016/j.peptides.2014.01.020
Both GLP-1 receptor agonists and metformin are known to cause gastrointestinal issues, but their side effect profiles differ
However, these treatments often come with side effects such as weight gain, digestive issues, and hypoglycemia, making long-term glycemic control challenging (10, 11)
4 Interestingly, early trials suggested DPP-4 may affect the immune system due to inhibition of T-cell activity in vitro
